Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 14, 2023 -- Genelux Corporation , a late clinical-stage immuno-oncology company, today announced that on September 11, 2023, the Company’s Board of Directors ...